{"agitation": 3.69, "anaphylactic reaction": 2.8, "cardiac arrest": 2.31, "choking": 11.13, "condition aggravated": 2.31, "cyanosis": 17.68, "death": 2.96, "disease progression": 2.05, "general physical health deterioration": 2.5, "inappropriate schedule of product administration": 4.08, "infusion related reaction": 121.99, "nasopharyngitis": 2.06, "oxygen saturation decreased": 6.15, "pneumonia": 4.05, "product dose omission issue": 2.66, "respiratory disorder": 18.54, "respiratory distress": 10.85, "respiratory failure": 5.19, "rhinorrhoea": 3.02, "seizure": 3.9, "tremor": 2.75, "upper respiratory tract infection": 9.9, "urticaria": 6.66, "wheezing": 4.68}